COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumor subtype and patient demographics: a prospective cohort study
Lee, L. Y. W., Cazier, J.-B., Starkey, T., Briggs, S. E. W., Arnold, R., Bisht, V., Booth, S., Campton, N. A., Cheng, V. W. T., Collins, G., Curley, H. M., Earwaker, P., Fittall, M. W., Gennatas, S., Goel, A., Hartley, S., Hughes, D. J., Kerr, D., Lee, A. J. X., … Hudson, Z. (2020). COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: A prospective cohort study. The Lancet Oncology, 0(0). https://doi.org/10.1016/S1470-2045(20)30442-3
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Obesity Could Shift Severe COVID-19 Disease to Younger Ages
Implications of COVID-19 for patients with pre-existing digestive diseases
Comorbidities and multi-organ injuries in the treatment of COVID-19
Liver injury in COVID-19: management and challenges
COVID-19: consider cytokine storm syndromes and immunosuppression
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: A multicentre, retrospective, cohort study
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
COVID-19 in patients with HIV: clinical case series
Maintaining HIV care during the COVID-19 pandemic
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumor subtype and patient demographics: a prospective cohort study
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study